RxDoctor Payments Data

Gregory Leghart, MD

Physical Medicine & Rehabilitation · Mechanicsville, VANPI 1255386264

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $644 and has fallen 97.7% since, to $15 in 2022.

$976in general payments, 2019–2025

Across 40 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tepha Inc$234
  • Merz North America, Inc.$166
  • AbbVie$140
  • Novartis$114
  • Ipsen Biopharmaceuticals, Inc$100
  • Amgen$56
  • plus $167 from 8 others

What the payments were for

  • Food & beverage$976100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$976 in reported general payments places this provider in the 75th percentile of 231 physical medicine & rehabilitation providers in Virginia.

See all physical medicine & rehabilitation providers in Virginia

Medicare billing

Part B allowed, 2024
$149,977
Medicare patients
312
Services billed
1,850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$12,931
BrilintaTicagrelor16$9,755
Atorvastatin Calcium94$1,092
Potassium Chloride30$625
Amiodarone Hcl13$547
Pantoprazole Sodium32$464
Losartan Potassium37$332
ClopidogrelClopidogrel Bisulfate32$281
Gabapentin24$272
Amlodipine Besylate32$218
Trazodone Hcl29$208
Tamsulosin Hcl11$203
Carvedilol20$194
Sertraline Hcl16$173
Baclofen14$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$12,93122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 231 physical medicine & rehabilitation providers in Virginia.

Other physical medicine & rehabilitation in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →